Vaccine produced by the University of Oxford and the Astrazeneca laboratory.| Photo: Reproduction Oxford University / Facebook

The city of Manaus and the state of Amazonas are investigating the death of an 83-year-old man who died the next day after taking a dose of the vaccine developed by the University of Oxford and produced by the manufacturer AstraZeneca. The Immunobiological Reference Center (Crie), linked to the Health Surveillance Foundation (FVS) and the State Health Secretariat of Amazonas (SES), has up to seven days to issue a report. Local health agencies have already started procedures for collecting epidemiological data and biological material for examinations and analyzes.

According to a relative of the elderly, he was showing symptoms of flu, but as they were “mild”, the family decided to take him to vaccinate. The dose was received on Friday (29). “He also had high blood pressure, but he was taking medication. Now, just knowing the report. We will wait, but we think it is better to inform the FVS by coincidence”, said the relative. The elderly died on Saturday morning (30).

In the first two days of vaccination for the elderly, the number of people aged 80 and over vaccinated was less than expected at the fixed posts and drive-thrus across the city. According to the city, around 4,000 people aged 80 and over were vaccinated. Vaccination for this public started on Friday and the city did not register queues or agglomerations. The expectation was that twice as many people had been vaccinated. The schedule continues until the immunizations run out.